Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib price?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?How many years does kadcyla's market exclusivity last?Motegrity ingredients?Brenzavvy discontinuation?
See the DrugPatentWatch profile for Fidaxomicin
Fidaxomicin (Dificid) received FDA approval on April 27, 2011. [1]
The initial FDA approval in 2011 established fidaxomicin for treatment of Clostridioides difficile infection (CDI); later updates to prescribing information can occur without changing the original approval date. [1]
You can verify the approval date through the FDA’s product information and the drug label associated with Dificid. [1] Sources: [1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202-444&search=Fidaxomicin
Other Questions About Fidaxomicin :